This Is MS Multiple Sclerosis Community: Knowledge & Support

Why don't they prescribe anti-inflammatories like naprosyn or ibuprophen to us? They use steroids to stop the inflammation if we have an attack. They like the anti-inflammatory effect of many new drugs. They are trying to stop the damage of the inflammation of the myelin....
We use anti-inflammatories when people have migraines so they do reach the brain.
I may have missed the explanation before I joined this forum. I will ask my neuro on Saturday.... later... Carolew

It's the only drug that i can feel the good affects from but my my neuro won't prescribe them to me because of the possible damage steroids could do to me long term, give me a break "it's ms" lets live in the now!!!

hi carole i believe i read a study that attempted to utilize standard anti-inflammatory drugs but they were ineffective. as in, i think it was in the 60s they tried to treat it with aspirin and such. that's all i know about it

carolew,

There was a recent trial on MS, aspirin, and fatigue. It was a placebo-controlled, randomized cross-over double-blinded trial, which is good design and especially needed for something subjective like fatigue. It was a small study (N=30), but with randomized crossover design you don't need as many subjects. Aspirin helped with fatigue in this study. Here is abstract, there is a comment in the same journal but I can't view that:


^^^^^^^^^^^^^
Neurology. 2005 Apr 12;64(7):1267-9. Related Articles, Links


Comment in:
Neurology. 2005 Apr 12;64(7):1111-2.

A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis.

Wingerchuk DM, Benarroch EE, O'Brien PC, Keegan BM, Lucchinetti CF, Noseworthy JH, Weinshenker BG, Rodriguez M.

Department of Neurology Mayo Clinic, Scottsdale, AZ 85259, USA. wingerchuk.dean@mayo.edu

Pharmacotherapeutic options for multiple sclerosis (MS)-related fatigue are limited. Thirty patients were randomly assigned to aspirin (ASA) 1,300 mg/day or placebo in a double-blind crossover study. Results favored ASA for the main clinical outcomes: Modified Fatigue Impact Scale scores (p = 0.043) and treatment preference (p = 0.012). There were no significant adverse effects. The results warrant further study and support a role for ASA-influenced mechanisms, perhaps immunologic, in the generation of MS-related chronic fatigue.

Publication Types:
Randomized Controlled Trial

PMID: 15824361 [PubMed - indexed for MEDLINE]

^^^^^^^^^^^

I couldn't find any other study that had an abstract, there were two trials from the early 1960s - those may have been what jimmylegs mentioned. Well, if aspirin doesn't help the overall disease course, at least this study indicates it may provide some fatigue relief.

Lisa

Thanks people...take care Carole